XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Interest Rate Swap
Common Stock
Treasury Stock
Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Interest Rate Swap
Balance (in shares) at Dec. 31, 2019     6,908 232          
Balance at Dec. 31, 2019 $ (36,916)   $ 69 $ (2,500) $ 24,026 $ (59,079)   $ 568  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (753)         (753)      
Issuance of equity grants, net (in shares)     190            
Issuance of equity grants, net 4   $ 1   3        
Interest rate cash flow hedge   $ (279)             $ (279)
Stock-based compensation 338       338        
Balance (in shares) at Mar. 31, 2020     7,098 232          
Balance at Mar. 31, 2020 (37,606)   $ 70 $ (2,500) 24,367 (59,832)   289  
Balance (in shares) at Dec. 31, 2019     6,908 232          
Balance at Dec. 31, 2019 (36,916)   $ 69 $ (2,500) 24,026 (59,079)   568  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 699                
Interest rate cash flow hedge (220)                
Balance (in shares) at Jun. 30, 2020     7,075 232          
Balance at Jun. 30, 2020 (36,018)   $ 70 $ (2,500) 24,444 (58,380)   348  
Balance (in shares) at Mar. 31, 2020     7,098 232          
Balance at Mar. 31, 2020 (37,606)   $ 70 $ (2,500) 24,367 (59,832)   289  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 1,452         1,452      
Interest rate cash flow hedge 59 59             59
Cancellation of equity grants, net (in shares)     (23)            
Cancellation of equity grants, net 0                
Stock-based compensation 77       77        
Balance (in shares) at Jun. 30, 2020     7,075 232          
Balance at Jun. 30, 2020 (36,018)   $ 70 $ (2,500) 24,444 (58,380)   348  
Balance (in shares) at Dec. 31, 2020     7,079 232          
Balance at Dec. 31, 2020 (31,305)   $ 71 $ (2,500) 24,596 (53,510)   38  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 1,888         1,888      
Issuance of equity grants, net (in shares)     106            
Issuance of equity grants, net 64   $ 1   63        
Interest rate cash flow hedge   29         $ 38   (9)
Stock-based compensation 95       95        
Balance (in shares) at Mar. 31, 2021     7,185 232          
Balance at Mar. 31, 2021 (29,229)   $ 72 $ (2,500) 24,754 (51,584)   29  
Balance (in shares) at Dec. 31, 2020     7,079 232          
Balance at Dec. 31, 2020 (31,305)   $ 71 $ (2,500) 24,596 (53,510)   38  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 4,382                
Interest rate cash flow hedge (20)                
Balance (in shares) at Jun. 30, 2021     7,181 232          
Balance at Jun. 30, 2021 (26,650)   $ 71 $ (2,500) 24,851 (49,090)   18  
Balance (in shares) at Mar. 31, 2021     7,185 232          
Balance at Mar. 31, 2021 (29,229)   $ 72 $ (2,500) 24,754 (51,584)   29  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 2,494         2,494      
Interest rate cash flow hedge (11) $ (11)             $ (11)
Cancellation of equity grants, net (in shares)     (4)            
Cancellation of equity grants, net (1)   $ (1)            
Stock-based compensation 97       97        
Balance (in shares) at Jun. 30, 2021     7,181 232          
Balance at Jun. 30, 2021 $ (26,650)   $ 71 $ (2,500) $ 24,851 $ (49,090)   $ 18